Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002130 · ClinicalTrials.gov registry record · NA
A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons
A NA study, sponsored by Otsuka America Pharmaceutical.
- Completed
- Registry status
- NA
- Development phase
NCT00002130 is a NA study that has completed, run by Otsuka America Pharmaceutical.
The verdict
NCT00002130, a NA study, has completed, sponsored by Otsuka America Pharmaceutical.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To examine the continued safety and tolerability of four doses of vesnarinone in HIV-infected patients who have completed a short-term study (less than 12 months on continuous treatment) of the drug.
Interventions
- DRUG Vesnarinone
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002130
The ClinicalTrials.gov registry entry for NCT00002130 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Otsuka America Pharmaceutical, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vesnarinone is the first listed.
NCT00002130 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002130 about?
NCT00002130 is a clinical study titled "A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons". To examine the continued safety and tolerability of four doses of vesnarinone in HIV-infected patients who have completed a short-term study (less than 12 months on continuous treatment) of the drug.
What is the current status of trial NCT00002130?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002130?
The interventions under investigation include: Vesnarinone (DRUG).
Who is sponsoring clinical trial NCT00002130?
This trial is sponsored by Otsuka America Pharmaceutical, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.